A story on Aderis Pharmaceuticals in the Aug. 29, 2003, issue of BioWorld Today should have said the company had about $26.3 million in cash and equivalents on June 30. Also, it should not have said DTI-0017 is in development.

Editor's note: The changes have been made on BioWorld Online.

No Comments